Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge

计划入组 13 人 · 首次发布于 2015 年 12 月 4 日

Evaluation of Long-Acting Muscarinic Antagonists in COPD

计划入组 15 人 · 首次发布于 2014 年 1 月 17 日

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists

计划入组 124,117 人 · 首次发布于 2022 年 7 月 14 日

long-acting muscarinic M3 antagonists (AstraZeneca)

Umeclidinium bromide(Anoro, Anoro Ellipta, Incruse Ellipta, Trelegy Ellipta, Rolufta Ellipta (previously Rolufta), Incruse Ellipta (previously Incruse))

C₂₉H₃₄NO₂ · Rx

HLB1-016

Long Island University

Costa Rica

NAM LONG PTY LTD

Australia

Long Grove Pharmaceuticals, LLC

United States

Zydus Healthcare to Conduct Phase III Trial for Glycopyrrolate/Indacaterol Inhaler

European Patent Office Upholds Umeclidinium-Vilanterol Combination Patent Despite Opposition Challenges

Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD